ADAR1's increased stake to 17.2% signals strong conviction from a sophisticated investor. Monitor for any future conversion to a 13D (activist) filing or additional accumulation, which could indicate a more active role.
Price Chart
Executive Summary
ADAR1 Capital Management, LLC filed an amended Schedule 13G disclosing a 17.2% passive stake in InMed Pharmaceuticals Inc. as of September 30, 2026, representing 943,668 common shares. This is an increase from the prior filing (Ikarian Capital, not ADAR1), indicating growing conviction from this investment adviser.
Key Financial Metrics
Key Facts
- ADAR1 Capital Management now holds 943,668 common shares of InMed Pharmaceuticals, representing 17.2% of shares outstanding.
- The stake is reported as passive (Rule 13d-1(b)), with no intent to change or influence control.
- The percentage is based on 5,493,735 shares outstanding as of September 2, 2026.
- Daniel Schneeberger, sole manager of ADAR1 Capital Management, is also listed as a reporting person with indirect beneficial ownership.
Financial Impact
17.2% ownership stake valued at approximately $[undisclosed] based on current market price.
Risk Factors
- Passive filing status could change if ADAR1 engages in activist activities.
- High concentration risk — a single large holder could influence stock price if they decide to sell.
- Micro-cap biotech with limited liquidity — large trades may have outsized price impact.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0001104659-26-114415 |
| Document: 0001104659-26-114415-index.html | 0001104659-26-114415 |
| Document: 0001104659-26-114415.txt | 0001104659-26-114415 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 7, 2026 18d ago | SC 13G/A | $1.33 | awaiting T+20 | — | $1.59 (+19.55%) |
Oct 2, 2026 24d ago | EFFECT | $1.33 | awaiting T+20 | — | $1.59 (+19.55%) |
Sep 18, 2026 5w ago | 8-K | $1.38 $1.37 | ▲ +1.06% | ▲ +0.15% | $1.59 (−15.22%) |
Sep 9, 2026 6w ago | 425 | $1.31 $1.33 | ▲ +1.53% | ▼ −0.60% | $1.59 (+21.37%) |
Jul 10, 2026 15w ago | 8-K | $1.57 $1.41 | ▲ +10.19% | ▲ +13.38% | $1.59 (−1.27%) |
Jul 2, 2026 16w ago | S-4 | $1.56 $1.50 | ▲ +3.85% | ▲ +3.43% | $1.59 (−1.92%) |
Jun 10, 2026 19w ago | Insider Cluster | $1.58 $1.66 | ▲ +5.06% | ▲ +3.17% | $1.59 (+0.63%) |
Jun 10, 2026 19w ago | 8-K | $1.51 $1.66 | ▲ +9.93% | ▲ +6.31% | $1.59 (+5.30%) |
May 19, 2026 22w ago | 425 | $1.60 $1.49 | ▼ −6.88% | ▼ −7.86% | $1.59 (−0.62%) |
May 19, 2026 22w ago | 8-K | $1.60 $1.49 | ▼ −6.88% | ▼ −7.86% | $1.59 (−0.62%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers